Person profile
Address
Boston, Massachusetts
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
MoonLake Immunotherapeutics
7 Jun 24
4/A
Enliven Therapeutics, Inc.
20 Feb 24
4
Enliven Therapeutics, Inc.
15 Feb 24
4
MoonLake Immunotherapeutics
12 Jun 23
4
Enliven Therapeutics, Inc.
6 Apr 23
3
Enliven Therapeutics, Inc.
27 Feb 23
4
MoonLake Immunotherapeutics
5 May 22
3
MoonLake Immunotherapeutics
15 Apr 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
6 Jun 24 | MLTX MoonLake Immunotherapeutics - Ordinary Shares | Option to Buy Class A ordinary shares, par value $0.0001 per share | Grant | Acquire A | No | No | 42.44 | 7,688 | 326.28 k | 7,688 |
13 Feb 24 | ELVN Enliven Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 14.85 | 16,835 | 250.00 k | 16,835 |
13 Feb 24 | ELVN Enliven Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 14.85 | 23,364 | 346.96 k | 23,364 |
8 Jun 23 | MLTX MoonLake Immunotherapeutics - Ordinary Shares | Option to Buy Class A ordinary shares, par value $0.0001 per share | Grant | Acquire A | No | No | 29.18 | 11,297 | 329.65 k | 11,297 |